Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Core EBITDA Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -27.6568.7394.61-11.1854.02

What is the latest Core EBITDA Growth ratio of NEULAND LABORATORIES ?

The latest Core EBITDA Growth ratio of NEULAND LABORATORIES is -27.65 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-27.65
Mar202468.73
Mar202394.61
Mar2022-11.18
Mar202154.02

How is Core EBITDA Growth of NEULAND LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -27.65
Negative
Mar2024 68.73
-27.35
Mar2023 94.61
Positive
Mar2022 -11.18
Negative
Mar2021 54.02 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Core EBITDA Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹19,134.7 Cr 13% 18.5% 22.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

13%

18.5%

22.4%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses